276 related articles for article (PubMed ID: 22108428)
1. Herpes simplex virus type 1-based amplicon vectors for fundamental research in neurosciences and gene therapy of neurological diseases.
Jerusalinsky D; Baez MV; Epstein AL
J Physiol Paris; 2012 Jan; 106(1-2):2-11. PubMed ID: 22108428
[TBL] [Abstract][Full Text] [Related]
2. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.
Geller AI; Yu L; Wang Y; Fraefel C
Exp Neurol; 1997 Mar; 144(1):98-102. PubMed ID: 9126158
[TBL] [Abstract][Full Text] [Related]
3. The use of herpes simplex virus vectors for gene therapy in neurological diseases.
Kennedy PG; Steiner I
Q J Med; 1993 Nov; 86(11):697-702. PubMed ID: 8265768
[TBL] [Abstract][Full Text] [Related]
4. [Advance of gene therapy for neurological diseases by direct in vivo gene transfer].
Li BY; Liu C; Wang HX
Sheng Li Ke Xue Jin Zhan; 1996 Jul; 27(3):215-20. PubMed ID: 9772359
[TBL] [Abstract][Full Text] [Related]
5. HSV trafficking and development of gene therapy vectors with applications in the nervous system.
Frampton AR; Goins WF; Nakano K; Burton EA; Glorioso JC
Gene Ther; 2005 Jun; 12(11):891-901. PubMed ID: 15908995
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.
Zibert A; Thomassen A; Müller L; Nguyen L; Glouchkova L; Fraefel C; Roskrow M; Meisel R; Dilloo D
Gene Ther; 2005 Dec; 12(23):1707-17. PubMed ID: 16034459
[TBL] [Abstract][Full Text] [Related]
7. [Herpes simplex type-1 virus-based vectors for gene therapy].
Ichikawa T; Saeki Y; Tamiya T; Chiocca EA; Ohmoto T
Nihon Rinsho; 2000 Apr; 58(4):822-7. PubMed ID: 10774201
[TBL] [Abstract][Full Text] [Related]
8. HSV-1-derived helper-independent defective vectors, replicating vectors and amplicon vectors, for the treatment of brain diseases.
Marconi P; Manservigi R; Epstein AL
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):169-83. PubMed ID: 20205051
[TBL] [Abstract][Full Text] [Related]
9. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
Saydam O; Glauser DL; Fraefel C
Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
[TBL] [Abstract][Full Text] [Related]
10. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors.
Melendez ME; Fraefel C; Epstein AL
Methods Mol Biol; 2014; 1144():81-98. PubMed ID: 24671678
[TBL] [Abstract][Full Text] [Related]
12. HSV-1-based amplicon vectors: design and applications.
Epstein AL
Gene Ther; 2005 Oct; 12 Suppl 1():S154-8. PubMed ID: 16231049
[TBL] [Abstract][Full Text] [Related]
13. Efficient and non-toxic gene transfer to cardiomyocytes using novel generation amplicon vectors derived from HSV-1.
Ferrera R; Cuchet D; Zaupa C; Revol-Guyot V; Ovize M; Epstein AL
J Mol Cell Cardiol; 2005 Jan; 38(1):219-23. PubMed ID: 15623439
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapy.
Fraefel C; Marconi P; Epstein AL
Methods Mol Biol; 2015; 1254():295-316. PubMed ID: 25431073
[TBL] [Abstract][Full Text] [Related]
15. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
Fink DJ; Ramakrishnan R; Marconi P; Goins WF; Holland TC; Glorioso JC
Clin Neurosci; 1995-1996; 3(5):284-91. PubMed ID: 8914795
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons.
Müller L; Saydam O; Saeki Y; Heid I; Fraefel C
J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700
[TBL] [Abstract][Full Text] [Related]
17. Delivery of herpes simplex virus amplicon-based vectors to the dentate gyrus does not alter hippocampal synaptic transmission in vivo.
Dumas T; McLaughlin J; Ho D; Meier T; Sapolsky R
Gene Ther; 1999 Oct; 6(10):1679-84. PubMed ID: 10516716
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a novel foreign gene delivery system combining an HSV amplicon with an attenuated replication-competent virus, HSV-1 HF10.
Zhang L; Daikoku T; Ohtake K; Ohtsuka J; Nawa A; Kudoh A; Iwahori S; Isomura H; Nishiyama Y; Tsurumi T
J Virol Methods; 2006 Nov; 137(2):177-83. PubMed ID: 16854473
[TBL] [Abstract][Full Text] [Related]
20. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
